Variant report
Variant | nsv595432 |
---|---|
Chromosome Location | chr4:132177261-132208026 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:63)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr4:132179544-132179772 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | BCL11A | chr4:132178410-132178696 | GM12878 | blood: | n/a | n/a |
3 | BCL11A | chr4:132178348-132178643 | GM12878 | blood: | n/a | chr4:132178369-132178378 |
4 | BHLHE40 | chr4:132178402-132178703 | GM12878 | blood: | n/a | n/a |
5 | CCNT2 | chr4:132205064-132205471 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr4:132179607-132179807 | HepG2 | liver: | n/a | chr4:132179698-132179709 |
7 | CEBPB | chr4:132179571-132179733 | A549 | lung: | n/a | chr4:132179698-132179709 |
8 | CEBPB | chr4:132179496-132179815 | ECC-1 | luminal epithelium: | n/a | chr4:132179698-132179709 |
9 | CEBPB | chr4:132179525-132179882 | H1-hESC | embryonic stem cell: | n/a | chr4:132179698-132179709 |
10 | CEBPB | chr4:132179537-132179884 | ECC-1 | luminal epithelium: | n/a | chr4:132179698-132179709 |
11 | CEBPB | chr4:132184264-132184515 | HepG2 | liver: | n/a | chr4:132184363-132184376 chr4:132184363-132184374 chr4:132184365-132184376 |
12 | CTCF | chr4:132192800-132192950 | GM12867 | blood: | n/a | n/a |
13 | E2F4 | chr4:132198917-132199101 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | E2F4 | chr4:132183895-132184448 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | E2F4 | chr4:132202858-132203105 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | E2F4 | chr4:132201577-132201932 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | EBF1 | chr4:132178395-132178589 | GM12878 | blood: | n/a | n/a |
18 | EBF1 | chr4:132200645-132200808 | GM12878 | blood: | n/a | n/a |
19 | EP300 | chr4:132178437-132178610 | GM12878 | blood: | n/a | n/a |
20 | EP300 | chr4:132178403-132178739 | GM12878 | blood: | n/a | n/a |
21 | FAM48A | chr4:132189387-132189511 | GM12878 | blood: | n/a | n/a |
22 | FOS | chr4:132179522-132179855 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr4:132183840-132184538 | MCF10A-Er-Src | breast: | n/a | chr4:132184283-132184292 |
24 | FOS | chr4:132178828-132179104 | MCF10A-Er-Src | breast: | n/a | chr4:132179002-132179012 chr4:132179002-132179012 chr4:132179002-132179012 |
25 | FOS | chr4:132179597-132179800 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | FOS | chr4:132179552-132179818 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | FOS | chr4:132179525-132179855 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | FOS | chr4:132178849-132179103 | MCF10A-Er-Src | breast: | n/a | chr4:132179002-132179012 chr4:132179002-132179012 chr4:132179002-132179012 |
29 | FOS | chr4:132178903-132179055 | MCF10A-Er-Src | breast: | n/a | chr4:132179002-132179012 chr4:132179002-132179012 chr4:132179002-132179012 |
30 | FOS | chr4:132183944-132184517 | MCF10A-Er-Src | breast: | n/a | chr4:132184283-132184292 |
31 | FOS | chr4:132183943-132184535 | MCF10A-Er-Src | breast: | n/a | chr4:132184283-132184292 |
32 | FOS | chr4:132183964-132184539 | MCF10A-Er-Src | breast: | n/a | chr4:132184283-132184292 |
33 | GATA3 | chr4:132183481-132183556 | SH-SY5Y | brain: | n/a | n/a |
34 | JUND | chr4:132179643-132179787 | HepG2 | liver: | n/a | n/a |
35 | JUND | chr4:132179538-132179833 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | MAZ | chr4:132180400-132180414 | HepG2 | liver: | n/a | n/a |
37 | MYC | chr4:132184127-132184400 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | MYC | chr4:132179629-132179756 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | MYC | chr4:132184040-132184468 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | MYC | chr4:132179572-132179830 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | NFYB | chr4:132181655-132181861 | GM12878 | blood: | n/a | chr4:132181708-132181718 chr4:132181706-132181720 |
42 | PBX3 | chr4:132178401-132178529 | GM12878 | blood: | n/a | n/a |
43 | POLR2A | chr4:132186698-132186764 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | POLR2A | chr4:132202112-132202287 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | POLR2A | chr4:132196264-132196420 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | POLR2A | chr4:132177560-132177615 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | POLR2A | chr4:132200590-132200904 | H1-neurons | neurons: | n/a | n/a |
48 | SETDB1 | chr4:132206862-132207249 | U2OS | brain: | n/a | n/a |
49 | STAT3 | chr4:132183942-132184445 | MCF10A-Er-Src | breast: | n/a | chr4:132184338-132184347 chr4:132184339-132184348 |
50 | STAT3 | chr4:132184135-132184466 | MCF10A-Er-Src | breast: | n/a | chr4:132184338-132184347 chr4:132184339-132184348 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-224P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192201219 | chr4:132178601-132178602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563631059 | chr4:132178648-132178649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529262931 | chr4:132178699-132178700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549445516 | chr4:132178711-132178712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572527990 | chr4:132178819-132178820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559786235 | chr4:132178849-132178850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528553636 | chr4:132178856-132178857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs66775392 | chr4:132178860-132178861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115607085 | chr4:132178878-132178879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138251838 | chr4:132178923-132178924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538180449 | chr4:132179038-132179039 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558065969 | chr4:132179140-132179141 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537686027 | chr4:132179221-132179222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550981829 | chr4:132179237-132179238 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141892808 | chr4:132179248-132179249 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536554416 | chr4:132179323-132179324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376381581 | chr4:132179325-132179326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11938816 | chr4:132179341-132179342 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs6838335 | chr4:132179357-132179358 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs200266330 | chr4:132179404-132179405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150633494 | chr4:132179413-132179414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139896350 | chr4:132179436-132179437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6534832 | chr4:132179527-132179528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541911760 | chr4:132179617-132179618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184410790 | chr4:132179676-132179677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189562275 | chr4:132179680-132179681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181841058 | chr4:132179694-132179695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542951772 | chr4:132179728-132179729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115517464 | chr4:132179791-132179792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528525167 | chr4:132179793-132179794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575541164 | chr4:132179809-132179810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149413248 | chr4:132179841-132179842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377006211 | chr4:132179884-132179885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565419337 | chr4:132179940-132179941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531008399 | chr4:132179958-132179959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551109989 | chr4:132179987-132179988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544538900 | chr4:132180041-132180042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184608880 | chr4:132180053-132180054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536514846 | chr4:132180064-132180065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371127834 | chr4:132180067-132180068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189126747 | chr4:132180090-132180091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147069310 | chr4:132180091-132180092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs386679573 | chr4:132180097-132180098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs4490472 | chr4:132180099-132180100 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs550080895 | chr4:132180106-132180107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571366631 | chr4:132180117-132180118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571239620 | chr4:132180128-132180129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536750104 | chr4:132180214-132180215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs146357956 | chr4:132180219-132180220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs573894925 | chr4:132180228-132180229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:132178600-132178800 | Enhancers | Brain Substantia Nigra | brain |
2 | chr4:132178800-132179600 | Weak transcription | Brain Substantia Nigra | brain |
3 | chr4:132179000-132180000 | Enhancers | Brain Inferior Temporal Lobe | brain |
4 | chr4:132179400-132180400 | Enhancers | Brain Hippocampus Middle | brain |
5 | chr4:132179600-132180000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr4:132179600-132180400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr4:132179600-132180600 | Enhancers | Brain Cingulate Gyrus | brain |
8 | chr4:132179600-132180600 | Enhancers | Brain Substantia Nigra | brain |